Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211229200 on December 10, 2002

J. Biol. Chem., Vol. 278, Issue 9, 7553-7557, February 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/9/7553    most recent
M211229200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jodo, S.
Right arrow Articles by Ju, S.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jodo, S.
Right arrow Articles by Ju, S.-T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Anti-CD95-induced Lethality Requires Radioresistant Fcgamma RII+ Cells
A NOVEL MECHANISM FOR FULMINANT HEPATIC FAILURE*

Satoshi JodoDagger , John T. Kung§, Sheng Xiao, Derek V. Chan, Seiichi Kobayashi||, Masatoshi Tateno**, Robert LafyatisDagger , and Shyr-Te JuDagger Dagger Dagger §§

From the Dagger  Arthritis Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, § Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, the  Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, the || Department of Laboratory Technology, College of Medical Technology, Hokkaido University, Hokkaido, Japan, the ** Department of Pathology, Sapporo City General Hospital, Sapporo, Japan, and Dagger Dagger  Division of Rheumatology and Immunology, Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia 22908-0412

The Jo2 anti-mouse CD95 monoclonal antibody induces lethality in mice characterized by hepatocyte death and liver hemorrhage. Mice bearing a defect in Fas expression or in the Fas-mediated apoptotic pathway are resistant to Jo2. Here we show that Fcgamma RII knockout mice or mice with monoclonal antibody-blocked Fcgamma RII are also resistant to Jo2. The critical Fcgamma RII+ cells are radioresistant and could not be reconstituted with splenic cells. Death of sinusoidal lining cells and destruction of sinusoids were observed, consistent with the characteristic liver hemorrhage and the selective Fcgamma RII expression in sinusoidal lining cells but not hepatocytes. Hemorrhage developed coincident with hepatocyte death and the sharp rise of serum alanine aminotransferase and alanine aminotransferase. Invariably, moribund mice showed severe liver hemorrhage and destruction of sinusoids. The data demonstrate a novel mechanism by which the destruction of liver sinusoids, induced by the Jo2-mediated co-engagement of Fas and Fcgamma RII, leads to severe hemorrhage and lethal fulminant hepatitis.


* This work was supported by National Institutes of Health Grants AI-36938 and ES-10244.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§§ To whom correspondence and reprint requests should be addressed: Division of Rheumatology and Immunology, Dept. of Internal Medicine, University of Virginia Health System, P. O. Box 800412, Charlottesville, VA 22908-0412. Tel.: 434-243-6358; Fax: 434-243-6454; E-mail: sj8r@virginia.edu.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. Leifeld, K. Fink, G. Debska, M. Fielenbach, V. Schmitz, T. Sauerbruch, and U. Spengler
Anti-Apoptotic Function of Gelsolin in Fas Antibody-Induced Liver Failure in Vivo
Am. J. Pathol., March 1, 2006; 168(3): 778 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. Haouzi, S. Baghdiguian, G. Granier, P. Travo, P. Mangeat, and U. Hibner
Three-dimensional polarization sensitizes hepatocytes to Fas/CD95 apoptotic signalling
J. Cell Sci., June 15, 2005; 118(12): 2763 - 2773.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
D. C. Spierings, E. G. de Vries, E. Vellenga, F. A. van den Heuvel, J. J. Koornstra, J. Wesseling, H. Hollema, and S. de Jong
Tissue Distribution of the Death Ligand TRAIL and Its Receptors
J. Histochem. Cytochem., June 1, 2004; 52(6): 821 - 831.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement